ArticleAmerican journal of translational research2021

MiR-18a-5p acts as a novel serum biomarker for venous malformation and promotes angiogenesis by regulating the thrombospondin-1/P53 signaling axis.

Liming Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.